# EDGAR Filing Document

**Accession Number:** 0001888014
**File Stem:** 0001213900-25-092854
**Filing Date:** 2025-9
**Character Count:** 1922
**Document Hash:** 5a8ae0257460f81e7a7935a8cb46002e
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-092854.hdr.sgml**: 20260128

**ACCESSION NUMBER**: 0001213900-25-092854

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250929

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AKANDA CORP.
- **CENTRAL INDEX KEY:** 0001888014
- **STANDARD INDUSTRIAL CLASSIFICATION:** MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** A6
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 1A, 1B LEAROYD ROAD
- **CITY:** NEW ROMNEY
- **STATE:** X0
- **ZIP:** TN28 8XU
- **BUSINESS PHONE:** 442034889514

**MAIL ADDRESS:**
- **STREET 1:** 77 KING STREET WEST, SUITE 400
- **STREET 2:** C/O DENTONS CANADA LLP
- **CITY:** TORONTO
- **STATE:** A6
- **ZIP:** M5K 0A1

**AKANDA CORP.**

**c/o Gowling WLG (Canada) LLP**

**100 King St. W, Suite 1600**

**Toronto, ON M5X 1G5, Canada**

**Tel: +1 (416) 862-7525**

September 26, 2025

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

100 F. St., N.E.

Washington, D.C. 20549

Re: Request for Acceleration of Effectiveness of Registration Statement on Form F-1 (File No. 333-290367)

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Akanda Corp. (the "<u>Registrant</u>") hereby requests the acceleration of the effective date of the above-referenced Registration Statement on Form F-1 (File No. 333-290367) so that it will become effective on Monday, September 29, 2025 at 4:00 p.m.., Eastern Time, or as soon thereafter as practicable.

---

| | |
|:---|:---|
| Very truly yours, | Very truly yours, |
| **AKANDA CORP.** | **AKANDA CORP.** |
| By: | */s/ Katharyn Field* |
| Name: | Katharyn Field |
| Title: | Interim Chief Executive Officer & Director |

---